SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023640
Filing Date
2020-05-08
Accepted
2020-05-08 17:02:07
Documents
77
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20200331.htm 10-Q 1705209
2 EX-31.1 eypt-ex311_22.htm EX-31.1 16141
3 EX-31.2 eypt-ex312_21.htm EX-31.2 16177
4 EX-32.1 eypt-ex321_20.htm EX-32.1 5536
5 EX-32.2 eypt-ex322_19.htm EX-32.2 5612
  Complete submission text file 0001564590-20-023640.txt   7404689

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eypt-20200331.xml EX-101.INS 1581857
7 XBRL TAXONOMY EXTENSION SCHEMA eypt-20200331.xsd EX-101.SCH 75145
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20200331_cal.xml EX-101.CAL 51857
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20200331_def.xml EX-101.DEF 251919
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20200331_lab.xml EX-101.LAB 527158
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20200331_pre.xml EX-101.PRE 404300
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 20861521
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences